Literature DB >> 19151034

Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort.

S A Chambers1, R Raine, A Rahman, D Isenberg.   

Abstract

OBJECTIVE: It has been suggested that low adherence may contribute to poor clinical outcomes in patients with SLE. In this study, we explored the reasons why patients with lupus did or did not take their medications as prescribed.
METHODS: Questionnaires including a 10-cm visual analogue scale (VAS) to assess self-reported adherence to prescribed medications were distributed to 315 patients with SLE. The responses were used to select a purposive sample of subjects who participated in interviews to discuss why they did or did not take their medications.
RESULTS: Of the 315 patients, 220 (70%) completed the questionnaire. Thirty-three patients were interviewed. Themes explaining why patients took their medications regularly included: the fear of worsening disease, the belief that there was no effective therapeutic alternative to their prescribed medications, lack of knowledge about SLE to allow confidence in changing medications and feelings of moral obligation or responsibility to others. Themes explaining why patients did not take their medications regularly included: the belief that lupus could and should be controlled using alternative methods, the belief that long-term use of drugs was not necessary, the fear of drug adverse effects, practical difficulties in obtaining medications, and poor communication between patients and doctors.
CONCLUSION: The patients' reasons for taking or not taking their medications largely related to previous experiences with the disease and/or drugs. However, improvements in communication between doctors and patients may promote better adherence in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151034     DOI: 10.1093/rheumatology/ken479

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  28 in total

1.  Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Sofia de Achaval; Maria E Suarez-Almazor
Journal:  Int J Clin Rheumtol       Date:  2010-06-01

Review 2.  Pitfalls and opportunities in measuring patient outcomes in lupus.

Authors:  Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

3.  A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Authors:  Nathalie Costedoat-Chalumeau; Frédéric Houssiau; Peter Izmirly; Véronique Le Guern; Sandra Navarra; Meenakshi Jolly; Guillermo Ruiz-Irastorza; Gabriel Baron; Eric Hachulla; Nancy Agmon-Levin; Yehuda Shoenfeld; Francesca Dall'Ara; Jill Buyon; Christophe Deligny; Ricard Cervera; Estibaliz Lazaro; Holy Bezanahary; Gaëlle Leroux; Nathalie Morel; Jean-François Viallard; Christian Pineau; Lionel Galicier; Ronald Van Vollenhoven; Angela Tincani; Hanh Nguyen; Guillaume Gondran; Noel Zahr; Jacques Pouchot; Jean-Charles Piette; Michelle Petri; David Isenberg
Journal:  Clin Pharmacol Ther       Date:  2017-11-09       Impact factor: 6.875

4.  Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate.

Authors:  Amal B Abdul-Sattar; Sahar A Abou El Magd
Journal:  Rheumatol Int       Date:  2014-11-26       Impact factor: 2.631

5.  Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China.

Authors:  Le Zhang; Shikai Geng; Liping Qian; Shuang Ye; Xiaodong Wang; Guohong Lu; Yang Ding; Ting Li
Journal:  Int J Clin Pharm       Date:  2019-06-25

6.  Pilot Intervention to Improve Medication Adherence among Patients with Systemic Lupus Erythematosus Using Pharmacy Refill Data.

Authors:  Kai Sun; Amanda M Eudy; Jennifer L Rogers; Lisa G Criscione-Schreiber; Rebecca E Sadun; Jayanth Doss; Mithu Maheswaranathan; Ann Cameron Barr; Lena Eder; Amy L Corneli; Hayden B Bosworth; Megan E B Clowse
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-11-05       Impact factor: 5.178

7.  Barriers to Taking Medications for Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers, and Clinic Staff.

Authors:  Kai Sun; Amy L Corneli; Carrie Dombeck; Teresa Swezey; Jennifer L Rogers; Lisa G Criscione-Schreiber; Rebecca E Sadun; Amanda M Eudy; Jayanth Doss; Hayden B Bosworth; Megan E B Clowse
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-06-01       Impact factor: 5.178

8.  Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized.

Authors:  Michael E Farhangian; William W Huang; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2015-04-22

9.  The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort.

Authors:  Marline L Squance; Glenn E M Reeves; Howard Bridgman
Journal:  Int J Chronic Dis       Date:  2014-11-20

10.  Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort.

Authors:  Rachel Gross; Jennifer Graybill; Dawn Wahezi; Nicole C Jordan; Chaim Putterman; Irene Blanco
Journal:  J Clin Cell Immunol       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.